By Josh Beckerman Evelo Biosciences shares fell 58% as the company said it will discontinue EDP2939 after a Phase 2 study in moderate psoriasis didn't meet.
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling around 50 points on Tuesday. The Dow traded down 0.09% to 33,954.39 while the NASDAQ fell 0.37% to 13,517.59. The S&P 500 also fell, dropping, 0.10% to 4,369.41.
CEPI s founding CEO to lead Wellcome—Chutes & Ladders fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Evelo Biosciences, Inc. (NASDAQ:EVLO – Get Free Report) saw a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 586,400 shares, an increase of 119.1% from the September 15th total of 267,700 shares. Based on an average daily trading volume, of 529,600 shares, the days-to-cover […]
Horizon Technology Finance Provides Third Quarter 2023 Portfolio Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.